MMP9 and non-small cell lung carcinoma: Similarly, Rab37 represents an anti-metastatic factor in non-small cell lung cancer (NSCLC) by inhibiting matrix metalloproteinase 9 (MMP9) activity both in vitro and in vivo [25,26].